| INNATE PHARMA EO -,05 |
| Frankreich |
| Gesundheit |
| FR0010331421 / A0LCUJ |
| IDD (Frankfurt) |
| FRA:IDD, ETR:IDD, IDD:GR |
| - |
| https://www.innate-pharma.. |
|
Innate Pharma S.A. is a global, clinical-stage biotechnology company specializing in oncology-focused immunotherapies that harness the innate immune system to combat cancer. Founded in 1999 by pioneers in innate immunity, the company leverages expert..
>Volltext.. |
| 107.67 Mio. EUR |
| 96.07 Mio. EUR |
| 2.8 Mio. EUR |
| -59.2 Mio. EUR |
| -49.46 Mio. EUR |
| -0.55 EUR |
| 22.7 Mio. EUR |
| 28.26 Mio. EUR |
| -52.67 Mio. EUR |
| 0.94 |
| -77.92% |
| 0.59% |
| - |
| - |
| - |
| - |
| INNATE PHARMA |
| 08.04.26 |
|
||||
|